Pfizer Protease Inhibitor for COVID-19

This video examines the new Pfizer protease inhibitor for COVID-19 and discusses the Pfizer EPIC-HR study result. How the Pfizer pill to treat Covid works is explained, and diagrams are used to show the way protease inhibitors inhibit SARS-CoV-2 viral proteases and prevent viral replication. The video brings viewers up-to-date with this exciting recent development and keeps them informed on this groundbreaking area of research. The Pfizer pill to treat Covid may soon become the standard of care for patients with mild-to-moderate Covid-19 symptoms, but just how great an impact the new Pfizer oral pill for Covid will have on the pandemic is yet to be seen. Nevertheless, viewers will be ahead of the curve for these new developments in the fight against COVID-19.

Chapters
0:00 Introduction
0:40 EPIC-HR Study
1:18 Risk factors for severe Covid-19 illness
1:49 EPIC study results
2:15 PAXLOVID
2:30 Protease inhibitors
2:42 How Pfizer pill works
3:37 Adverse events
3:48 Coadministration of Ritonavir
4:02 Paxlovid compared to Merck’s Molnupiravir
4:15 Summary